Your browser doesn't support javascript.
loading
MSA-VT Score for Assessment of Long-Term Prognosis after Electrical Storm Ablation.
Vatasescu, Radu; Cojocaru, Cosmin; Gondos, Viviana; Iorgulescu, Corneliu; Bogdan, Stefan; Onciul, Sebastian; Berruezo, Antonio.
Afiliação
  • Vatasescu R; Department of Cardiothoracic Pathology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Cojocaru C; Cardiology Department, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania.
  • Gondos V; Department of Cardiothoracic Pathology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Iorgulescu C; Cardiology Department, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania.
  • Bogdan S; Department of Medical Electronics and Informatics, Polytechnic University, 060042 Bucharest, Romania.
  • Onciul S; Cardiology Department, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania.
  • Berruezo A; Department of Cardiothoracic Pathology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Biomedicines ; 12(3)2024 Feb 22.
Article em En | MEDLINE | ID: mdl-38540108
ABSTRACT

INTRODUCTION:

Prognosis after electrical storm (ES) ablation remains severe, especially in patients with recurrent sustained monomorphic ventricular tachycardia (SMVT) or progressive heart failure (HF). However, single-factor-based prediction is suboptimal and may be refined by more complex algorithms. We sought to evaluate if a novel score MSA-VT (M = moderate/severe mitral regurgitation, S = severe HF at admission, A = atrial fibrillation at admission, VT = inducible SMVT after ablation) may improve prediction of death and recurrences compared to single factors and previous scores (PAINESD, RIVA and I-VT).

METHODS:

A total of 101 consecutive ES ablation patients were retrospectively analyzed over a 32.8-month (IQR 10-68) interval. The MSA-VT score was calculated as the sum of the previously mentioned factors' coefficients based on hazard ratio values in Cox regression analysis. The AUC for death prediction by MSA-VT was 0.84 (p < 0.001), superior to PAINESD (AUC 0.63, p = 0.03), RIVA (AUC 0.69, p = 0.02) and I-VT (0.56, p = 0.3). MSA-VT ≥ 3 was associated with significantly higher mortality during follow-up (52.7%, p < 0.001).

CONCLUSIONS:

Prediction by single factors and previously published scores after ES ablation may be improved by the novel MSA-VT score; however, this requires further external validation in larger samples.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2024 Tipo de documento: Article